tiprankstipranks
Advertisement
Advertisement
Conmed Earnings Call Balances Headwinds With Guidance
PremiumCompany AnnouncementsConmed Earnings Call Balances Headwinds With Guidance
1M ago
Conmed price target lowered to $40 from $43 at JPMorgan
Premium
The Fly
Conmed price target lowered to $40 from $43 at JPMorgan
1M ago
Michael Matson Reiterates Hold on Conmed as Slowing Organic Growth and Margin Pressure Offset 1Q26 Beat; Price Target Raised to $35.96
Premium
Ratings
Michael Matson Reiterates Hold on Conmed as Slowing Organic Growth and Margin Pressure Offset 1Q26 Beat; Price Target Raised to $35.96
1M ago
DraftKings, Eli Lilly downgraded: Wall Street’s top analyst calls
PremiumThe FlyDraftKings, Eli Lilly downgraded: Wall Street’s top analyst calls
3M ago
Maintaining a Neutral Stance Amid Persistent AirSeal Headwinds and Execution Challenges
Premium
Ratings
Maintaining a Neutral Stance Amid Persistent AirSeal Headwinds and Execution Challenges
3M ago
Conmed downgraded to Neutral from Overweight at Piper Sandler
Premium
The Fly
Conmed downgraded to Neutral from Overweight at Piper Sandler
3M ago
Conmed reports Q4 adjusted EPS $1.43, consensus $1.32
PremiumThe FlyConmed reports Q4 adjusted EPS $1.43, consensus $1.32
4M ago
Conmed sees FY26 adjusted EPS $4.30-$4.45, consensus $4.42
Premium
The Fly
Conmed sees FY26 adjusted EPS $4.30-$4.45, consensus $4.42
4M ago
CNMD Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
CNMD Earnings Report this Week: Is It a Buy, Ahead of Earnings?
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100